美股医疗保健行业-美国药品分销Q2预览:季度内趋势剖析

美股医疗保健行业-美国药品分销Q2预览:季度内趋势剖析

ID:19500487

大小:676.92 KB

页数:34页

时间:2018-10-02

美股医疗保健行业-美国药品分销Q2预览:季度内趋势剖析_第1页
美股医疗保健行业-美国药品分销Q2预览:季度内趋势剖析_第2页
美股医疗保健行业-美国药品分销Q2预览:季度内趋势剖析_第3页
美股医疗保健行业-美国药品分销Q2预览:季度内趋势剖析_第4页
美股医疗保健行业-美国药品分销Q2预览:季度内趋势剖析_第5页
资源描述:

《美股医疗保健行业-美国药品分销Q2预览:季度内趋势剖析》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、20July2018Americas/UnitedStatesEquityResearchHealthcareTechnology&Distribution3katie.tryhane@credit-suisse.comDrugDistributorUpdateSECTORREVIEW2QPreview:Dissectingintra-quartertrends■2QPreview&Themes:Sharesfordrugdistributors,includingAmerisourceBergen(ABC,Outperform),CardinalH

2、ealth(CAH,Outperform),andMcKesson(MCK,Underperform),arecurrentlytradingata7.9xFY+2EV/EBITDAonaverage,ameaningfuldiscounttotheir8.9xfive-yearhistoricalaverage,withongoingconcernsrelatedtodrugpricing,contractrenewals,andAmazonheadlinesreverberatingacrossthesupplychain,inadditionto

3、company-specificheadwindsrangingfromcontinuedintegrationheadwinds,Medicalsegmentwoes(CAH),andmanufacturingsuspensions(ABC).Still,ourviewisthatsomestabilityinthegenericdrugpricingenvironment(assupportedbyouranalysisandindustrycommentary)shouldsetupthedistributorsforpotentiallyles

4、svolatilereports,barringanymajorcontractshifts,andourfocusisincreasinglyoncontributionsfromfastergrowing,moreprofitable,andoftentimesmorecapitalefficientancillarybusinesses,relevanttoourthesesforoursupplychaincompanies,whereweviewABCasrelativelybetterpositioned.■LacklusterRxvolu

5、me,butmorestablegenericpricingdynamics:AccordingtoIQVIA,adj.prescriptionvolumedeclined1.0%inJune,adecelerationfromthe-0.5%trendexperiencedinbothMayandApril(2Qaveragevolumegrowthof-0.7%).BasedonouranalysisofthetotalgenericdrugsalesasreportedbyIQVIAonanunweightedbasis,thesell-side

6、ASPforgenerictherapeuticsfell11.2%(-4.9%weightedbysales)onaverageinMay,followinga13.8%decline(-5.1%weightedbysales)inApril,excludingLTMnewgenericlaunches.Moreover,accordingtoAprilNADACdata,asurveyperformedbytheCMStogaugetheaveragenationalacquisitioncostsforretailpharmaciesacross

7、theUS,73%ofallreportedgenericsexperiencedpricedeclinesinexcessof5%,onlyslightlyhigherthantheMarchexperience(68%).Forcontext,ongoinggenericpricedeflationoverthepastyear+,hasweighedondrugdistributors,aspricedeclineshaveledtolowergrossprofitdollars,andwhilewedonotexpectasignificant

8、reversalNT,thesupplychaingrouphasnotedstabilizi

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。